ACADIA PHARMACEUTICALS INC's ticker is ACAD and the CUSIP is 004225108. A total of 158 filers reported holding ACADIA PHARMACEUTICALS INC in Q3 2014. The put-call ratio across all filers is 0.09 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2015 | $1,143,000 | +28.4% | 27,300 | 0.0% | 0.12% | +30.7% |
| Q1 2015 | $890,000 | -97.3% | 27,300 | -97.3% | 0.09% | -97.5% |
| Q4 2014 | $32,617,000 | -75.1% | 1,027,300 | -80.5% | 3.50% | -77.3% |
| Q3 2014 | $130,733,000 | +10.2% | 5,280,000 | +0.6% | 15.45% | +28.9% |
| Q2 2014 | $118,598,000 | -11.4% | 5,250,000 | -4.5% | 11.99% | +24.9% |
| Q1 2014 | $133,816,000 | -16.6% | 5,500,000 | -14.3% | 9.60% | -48.7% |
| Q4 2013 | $160,434,000 | -19.8% | 6,419,898 | -11.9% | 18.69% | -10.5% |
| Q3 2013 | $200,133,000 | -4.4% | 7,285,510 | -36.8% | 20.89% | -24.7% |
| Q2 2013 | $209,266,000 | – | 11,529,810 | – | 27.75% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Finepoint Capital LP | 556,553 | $11,598,565 | 5.78% |
| Baker Brothers Advisors | 42,864,612 | $893,298,514 | 5.15% |
| RTW INVESTMENTS, LP | 11,576,537 | $241,255,031 | 5.09% |
| Palo Alto Investors LP | 2,405,793 | $50,136,726 | 4.74% |
| Birchview Capital, LP | 240,400 | $5,009,936 | 4.26% |
| EcoR1 Capital, LLC | 5,991,479 | $124,862,422 | 4.21% |
| EMERALD ADVISERS, LLC | 1,681,052 | $35,033,124 | 1.70% |
| EMERALD MUTUAL FUND ADVISERS TRUST | 1,303,988 | $27,175,110 | 1.64% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 179,702 | $3,739,599 | 1.26% |
| SECTOR GAMMA AS | 179,785 | $3,746,719 | 0.96% |